Latest News

BREAKTHROUGHS
POSTED BY PULMONARY FIBROSIS FOUNDATION ON 12/22/2010

The PFF has closely followed the health challenges facing first responders following the events of 9/11, especially as it relates to an increase in respiratory disorders, including pulmonary fibrosis being reported by first responders following their heroic recovery efforts, primarily due to a variety of toxic airborne exposures they faced during the cleanup.

Recently, first responders reac

BREAKTHROUGHS
POSTED BY PULMONARY FIBROSIS FOUNDATION ON 12/21/2010

Esbriet to be the first medicine approved for IPF patients in the EU

BRISBANE, Calif., Dec. 17, 2010 /PRNewswire via COMTEX/ -- InterMune, Inc.

BREAKTHROUGHS
POSTED BY PULMONARY FIBROSIS FOUNDATION ON 12/8/2010

The PFF has closely followed the health challenges facing first responders following the events of 9/11, especially as it relates to an increase in respiratory disorders, including pulmonary fibrosis being reported by first responders following their heroic recovery efforts, primarily due to a variety of toxic airborne exposures they faced during the cleanup.

BREAKTHROUGHS
POSTED BY PULMONARY FIBROSIS FOUNDATION ON 8/16/2010

Legislation sets up advisory board, patient registry

Contact: Susan Wheeler
Wednesday, August 4, 2010

Washington, DC – Legislation introduced today in the U.S. Senate would bring much-needed attention to a progressive and generally fatal disease that takes the lives of 40,000 people each year.

BREAKTHROUGHS
ON 4/29/2010

April 29, 2010

A small piece of RNA appears to play a big role in the development of idiopathic pulmonary fibrosis (IPF), according to lung disease researchers at the University of Pittsburgh School of Medicine. Their study, which is the first to examine microRNAs in the disease, is available online in the American Journal of Respiratory and Critical Care Medicine.

BREAKTHROUGHS
ON 2/3/2010

February 3, 2010

A simple blood test could predict which patients with the lung-scarring disease known as idiopathic pulmonary fibrosis (IPF) are soon to get far worse, an indicator that could one day influence their treatment, according to researchers at the University of Pittsburgh School of Medicine.

BREAKTHROUGHS
POSTED BY JENN ROSS ON 12/19/2008

Researchers at UT Southwestern Medical Center have determined that a mutation in a gene known for its role in defending the lungs against invading pathogens is responsible for some inherited cases of a lethal lung disease affecting older adults.